Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

about

Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

Item

http://www.wikidata.org/entity/Q36618644

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

@ast

Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

@en

type

Item

label

Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

@ast

Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

@en

prefLabel

Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

@ast

Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

@en

P1476

Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

@en

P2093

A Longheu

http://www.w3.org/2001/XMLSchema#string

A Nicolosi

http://www.w3.org/2001/XMLSchema#string

E Erdas

http://www.w3.org/2001/XMLSchema#string

F Medas

http://www.w3.org/2001/XMLSchema#string

G Pisano

http://www.w3.org/2001/XMLSchema#string

P2860

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?

An overview of the management of papillary and follicular thyroid carcinoma.

Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?

Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option?

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.

Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.

Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000.

P304

257-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.11138/GCHIR/2015.36.6.257

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luca Gordini

Pietro Giorgio Calò

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26888701

http://www.w3.org/2001/XMLSchema#string

P932

4767372

http://www.w3.org/2001/XMLSchema#string